C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
Provided By GlobeNewswire
Last update: Sep 9, 2024
Abstract Released Today Highlights Favorable Safety Profile and Early Evidence of Monotherapy Anti-Tumor Activity
Investor Webcast to be Held Friday, September 13, 2024 at 12:00 pm ET
Read more at globenewswire.com1.4
+0.15 (+12%)
Find more stocks in the Stock Screener
CCCC Latest News and Analysis
12 days ago - ChartmillWhich stocks are moving before the opening bell on Thursday?As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
